Skip to main content
Premium Trial:

Request an Annual Quote

Sequencing Start-up Genome Corp. Lands $250K in Seed Funding from Slater Fund

NEW YORK (GenomeWeb News) - Genome Corp., a sequencing start-up based in Providence, RI, has received a $250,000 seed capital investment from the Slater Technology Fund, the companies said today.
 
Genome Corp. was founded earlier this year to develop and commercialize a sequencing method it calls “massively parallel Sanger sequencing,” a single-molecule approach that is expected to "greatly accelerate the speed and significantly reduce the cost of genome sequencing," according to the firm.
 
Company co-founder and CSO, Kevin Ulmer, founded single-molecule sequencing company SEQ Ltd. in 1987. The firm was later purchased by Amersham Biosciences. Ulmer was also involved in forming Exact Sciences, and has served as a consultant at Helicos Biosciences.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.